Cigarette Smoking and Levels of Adrenal Androgens in Postmenopausal Women

New England Journal of Medicine

Volumn 318, Issue 26, 1988, Pages 1705-1709

  Khaw, Kay Tee ^a   Tazuke, Sallie ^a   Barrett Connor, Elizabeth ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; PRASTERONE SULFATE;

CIGARETTE SMOKING; HUMAN; MAJOR CLINICAL STUDY; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0023891022     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198806303182601     Document Type: Article

References (32)

1. Hammond EC. Smoking in relation to death rates of one million men and women. Natl Cancer Inst Monogr 1966; 19: 127–204.
2. Khaw K-T, Barrett-Connor E. Family history of heart attack: a modifiable risk factor? Circulation 1986; 74: 239–44.
3. Daniell HW. Osteoporosis of the slender smoker: vertebral compression factors and loss of metacarpal cortex in relation to postmenopausal cigarette smoking and lack of obesity. Arch Intern Med 1976; 136: 298–304.
4. Williams AR, Weiss NS, Ure CL, Ballard J, Daling JA. Effect of weight, smoking, and estrogen use on the risk of hip and forearm fractures in postmenopausal women. Obstet Gynecol 1982; 60: 695–9.
5. Weiss NS, Farewell VT, Szekely DR, English DR, Kiviat N. Oestrogens and endometrial cancer: effect of other risk factors on the association. Maturitas 1980; 2: 185–90.
6. Lawrence C, Tessaro I, Durgerian S, et al. Smoking, body weight, and early-stage endometrial cancer. Cancer 1987; 59: 1665–9.
7. Vessey M, Baron J, Doll R, McPherson K, Yeates D. Oral contraceptives and breast cancer: final report of an epidemiological study. Br J Cancer 1983; 47: 455–62.
8. Baron J. Smoking and estrogen-related disease. Am J Epidemiol 1984; 119: 9–22.
9. Willett W, Stampfer MJ, Bain C, et al. Cigarette smoking, relative weight, and menopause. Am J Epidemiol 1983; 117: 651–8.
10. Kaufman DW, Slone D, Rosenberg L, Miettinen OS, Shapiro S. Cigarette smoking and age at natural menopause. Am J Public Health 1980; 70: 420–2.
11. Thomford PJ, Mattison DR. The effect of cigarette smoking on female reproduction. J Arkansas Med Soc 1986; 82: 597–604.
12. Weisberg E. Smoking and reproductive health. Clin Reprod Fertil 1985; 3: 175–86.
13. Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL, Fishman J. Increased 2-hydroxylation of estradiol as a possible mechanism for the antiestrogenic effect of cigarette smoking. N Engl J Med 1986; 315: 1305–9.
14. Jensen J, Christiansen C, R⊘dbro P. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. N Engl J Med 1985; 313: 973–5.
15. Vermeulen A, Verdonck L. Sex hormone concentrations in post-menopausal women: relation to obesity, fat mass, age and years post-menopause. Clin Endocrinol (Oxf) 1978; 9: 59–66.
16. Siiteri PK. Steroid hormones and endometrial cancer. Cancer Res 1978; 38: 4360–6.
17. Barbieri RL, McShane PM, Ryan KJ. Constituents of cigarette smoke inhibit human granulosa cell aromatase. Fertil Steril 1986; 46: 232–6.
18. Friedman AJ, Ravnikar VA, Barbieri RL. Serum steroid hormone profiles in postmenopausal smokers and nonsmokers. Fertil Steril 1987; 47: 398–401.
19. Lapidus L, Lindstedt G, Lundberg PA, Bengtsson C, Gredmark T. Concentrations of sex-hormone binding globulin and corticosteroid binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of cardiovascular disease and overall mortality in postmenopausal women. Clin Chem 1986; 32: 146–52.
20. Lindholm J, Winkel P, Brodthagen U, Gyntelberg F. Coronary risk factors and plasma sex hormones. Am J Med 1982; 73: 648–51.
21. Klaiber EL, Broverman DM, Dalen JE. Serum estradiol levels in male cigarette smokers. Am J Med 1984; 77: 858–62.
22. Barrett-Connor E, Khaw K-T. Cigarette smoking and increased endogenous estrogen levels in men. Am J Epidemiol 1987; 126: 187–92.
23. Criqui MH, Barrett-Connor E, Austin M. Differences between respondents and non-respondents in a population-based cardiovascular disease study. Am J Epidemiol 1978; 108: 367–72.
24. Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984; 59: 551–5.
25. Anderson DC, Hopper BR, Lasley BL, Yen SSC. A simple method for the assay of eight steroids in small volumes of plasma. Steroids 1976; 28: 179–96.
26. Hopper BR, Yen SSC. Circulating concentrations of dehydroepiandrosterone and dehydroepiandrosterone sulfate during puberty. J Clin Endocrinol Metab 1975; 40: 458–61.
27. Rosner W. A simplified method for the quantitative determination of testosterone-estradiol-binding globulin activity in human plasma. J Clin Endocrinol Metab 1972; 34: 983–8.
28. Vermeulen A. Androgen secretion after age 50 in both sexes. Horm Res 1983; 18: 37–42.
29. Suzuki T, Ikeda H, Narita S, Shibata O, Waki S, Egashira K. Adrenal cortical secretion in response to nicotine in conscious and anaesthetized dogs. Q J Exp Physiol 1973; 58: 139–42.
30. Judd HL, Judd GE, Lucas WE, Yen SSC. Endocrine functions of the postmenopausal ovary. J Clin Endocrinol Metab 1974; 39: 1020–4.
31. Barrett-Connor E, Khaw K-T, Yen SSC. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 1986; 315: 1519–24.
32. Schwarz AG, Pashko LL, Henderson EE, et al. Dehydroepiandrosterone: an anti-obesity and anticarcinogenic agent. In: Bulbrook RB, Taylor BJ, eds. Commentaries on research in breast disease. New York: Alan R. Liss, 1983:113–29.